1. Bayesian sequential integration within a preclinical pharmacokinetic and pharmacodynamic modeling framework: Lessons learned. (1st April 2019) Authors: La Gamba, Fabiola; Jacobs, Tom; Geys, Helena; Jaki, Thomas; Serroyen, Jan; Ursino, Moreno; Russu, Alberto; Faes, Christel Journal: Pharmaceutical statistics Issue: Volume 18:Number 4(2019) Page Start: 486 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
2. P2‐011: Pharmacokinetic/Pharmacodynamic Modeling of CSF AB1‐40 Reduction in an Early Alzheimer's Disease Study of JNJ‐54861911, an Oral Bace1 Inhibitor. (1st July 2016) Authors: Russu, Alberto; Van Broeck, Bianca; Tesseur, Ina; Timmers, Maarten; Smekens, Pascale; Tritsmans, Luc; Van Nueten, Luc; Streffer, Johannes Journal: Alzheimer's & dementia Issue: Volume 12:Supplement 7S(2016)Part 12 Page Start: P612 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
3. Alzheimer's disease progression model using disability assessment for dementia scores from bapineuzumab trials. Issue 2 (21st July 2015) Authors: Xu, Steven X.; Samtani, Mahesh N.; Russu, Alberto; Adedokun, Omoniyi J.; Lu, Ming; Ito, Kaori; Corrigan, Brian; Raje, Sangeeta; Brashear, H. Robert; Styren, Scot; Hu, Chuanpu Journal: Alzheimer's & dementia Issue: Volume 1:Issue 2(2015) Page Start: 141 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
4. Profiling the dynamics of CSF and plasma Aβ reduction after treatment with JNJ‐54861911, a potent oral BACE inhibitor. Issue 3 (24th August 2016) Authors: Timmers, Maarten; Van Broeck, Bianca; Ramael, Steven; Slemmon, John; De Waepenaert, Katja; Russu, Alberto; Bogert, Jennifer; Stieltjes, Hans; Shaw, Leslie M.; Engelborghs, Sebastiaan; Moechars, Dieder; Mercken, Marc; Liu, Enchi; Sinha, Vikash; Kemp, John; Van Nueten, Luc; Tritsmans, Luc; Streffer... Journal: Alzheimer's & dementia Issue: Volume 2:Issue 3(2016) Page Start: 202 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
5. Alzheimer's disease assessment scale‐cognitive 11‐item progression model in mild‐to‐moderate Alzheimer's disease trials of bapineuzumab. Issue 3 (5th October 2015) Authors: Samtani, Mahesh N.; Xu, Steven X.; Russu, Alberto; Adedokun, Omoniyi J.; Lu, Ming; Ito, Kaori; Corrigan, Brian; Raje, Sangeeta; Brashear, H. Robert; Styren, Scot; Hu, Chuanpu Journal: Alzheimer's & dementia Issue: Volume 1:Issue 3(2015) Page Start: 157 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
6. O1‐10‐05: Pharmacodynamics of the Oral Bace Inhibitor JNJ‐54861911 in Early Alzheimer's Disease. (1st July 2016) Authors: Streffer, Johannes; Börjesson-Hanson, Anne; Van Broeck, Bianca; Smekens, Pascale; Timmers, Maarten; Tesseur, Ina; Tatikola, Kanaka; Russu, Alberto; Sinha, Vikash; Salvadore, Giacomo; Aguilar, Miguel; Frank, Anna; Matias-Guiu, Jorge; Boada, Mercè; Baquero, Miquel; Tritsmans, Luc; Van Nueten, Luc; ... Journal: Alzheimer's & dementia Issue: Volume 12:Supplement 7S(2016)Part 4 Page Start: P199 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
7. Paliperidone Palmitate Long-Acting Injectable Given Intramuscularly in the Deltoid Versus the Gluteal Muscle: Are They Therapeutically Equivalent?. Issue 6 (December 2016) Authors: Ravenstijn, Paulien; Samtani, Mahesh; Russu, Alberto; Hough, David; Gopal, Srihari Journal: Journal of clinical psychopharmacology Issue: Volume 36:Issue 6(2016) Page Start: Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
8. Pharmacokinetic-Pharmacodynamic Characterization of Relapse Risk for Paliperidone Palmitate 1-Month and 3-Month Formulations. Issue 6 (November 2019) Authors: Russu, Alberto; Savitz, Adam; Mathews, Maju; Gopal, Srihari; Feng, Yu; Samtani, Mahesh N. Journal: Journal of clinical psychopharmacology Issue: Volume 39:Issue 6(2019) Page Start: Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
9. Maintenance dose conversion between oral risperidone and paliperidone palmitate 1 month: Practical guidance based on pharmacokinetic simulations. Issue 6 (30th April 2018) Authors: Russu, Alberto; Kern Sliwa, Jennifer; Ravenstijn, Paulien; Singh, Arun; Mathews, Maju; Kim, Edward; Gopal, Srihari Journal: International journal of clinical practice Issue: Volume 72:Issue 6(2018) Page Start: n/a Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
10. Evaluating Potential QT Effects of JNJ‐54861911, a BACE Inhibitor in Single‐ and Multiple‐Ascending Dose Studies, and a Thorough QT Trial With Additional Retrospective Confirmation, Using Concentration‐QTc Analysis. (5th March 2018) Authors: Timmers, Maarten; Sinha, Vikash; Darpo, Borje; Smith, Brian; Brown, Randy; Xue, Hongqi; Ferber, Georg; Streffer, Johannes; Russu, Alberto; Tritsmans, Luc; Solanki, Bhavna; Bogert, Jennifer; Van Nueten, Luc; Salvadore, Giacomo; Nandy, Partha Journal: Journal of clinical pharmacology Issue: Volume 58:Number 7(2018) Page Start: 952 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗